Skip Navigation LinksHome > August 2010 - Volume 32 - Issue 6 > Moyamoya in a Child Treated With Interferon for Recurrent Os...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3181e5e1db
Clinical and Laboratory Observations

Moyamoya in a Child Treated With Interferon for Recurrent Osteosarcoma

Buchbinder, David MD, MSHS*; Steinberg, Gary MD, PhD; Linetsky, Michael MD; Casillas, Jacqueline MD, MSHS§

Collapse Box


Moyamoya is a cerebral vasculopathy of unknown etiology rarely described as a late effect after the treatment of childhood cancer. We describe a 12-year-old female who developed moyamoya after the completion of systemic chemotherapy, surgery, and adjuvant interferon α for osteosarcoma with pulmonary metastases. Given the importance of characterizing late effects after the treatment of childhood cancer, the potential role of interferon α in the development of moyamoya is discussed.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.